Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
Author(s) -
Dae Joong Kang,
Genta Kakiyama,
Naga S. Betrapally,
Jeremy Herzog,
Hiroshi Nittono,
Phillip B. Hylemon,
Huiping Zhou,
Ian M. Carroll,
Jing Yang,
Patrick M. Gillevet,
Chunhua Jiao,
Hajime Takei,
William M. Pandak,
Takashi Iida,
Douglas M. Heuman,
Sili Fan,
Oliver Fiehn,
Takao Kurosawa,
Masoumeh Sikaroodi,
R. Balfour Sartor,
Jasmohan S. Bajaj
Publication year - 2016
Publication title -
clinical and translational gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.673
H-Index - 35
ISSN - 2155-384X
DOI - 10.1038/ctg.2016.44
Subject(s) - rifaximin , glutamine , hyperammonemia , medicine , gut flora , barrier function , hepatic encephalopathy , inflammation , bile acid , glutaminase , immunology , antibiotics , microbiology and biotechnology , biochemistry , chemistry , cirrhosis , biology , amino acid
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom